6th February, 2012
Recruitment is open for a study to assess if oral investigational medication (teriflunomide) can reduce MS relapses in patients already treated with Interferon
Read More
25th January, 2012
A review of Gilenya by the EMA has been initiated following the report of a patient in the USA who died 24 hours after taking Gilenya. The review also includes a total of 11 deaths worldwide, however the
Read More
9th December, 2011
The largest international annual conference on basic and clinical research in MS was held in Amsterdam recently by the European Committee for Treatment and Research in MS (ECTRIMS). Results of several
Read More
9th December, 2011
Do you have a diagnosis of MS and reside in the greater Sydney area? You may be interested in taking part in an important research study.
Read More
15th November, 2011
The results of the phase III trial of alemtuzumab and five year follow-up results were recently released.
Read More
17th October, 2011
Sourcing reliable information on treatments for MS – Cochrane Reviews
Read More
5th September, 2011
The new oral treatment for relapsing remitting MS, Gilenya®, is now available for PBS reimbursement
Read More
1st June, 2011
For people with MS, especially those not responding to currently available therapies, clinical trials and research may provide early access to new treatments.
Read More
1st December, 2010
Current disease-modifying drugs for MS have so far required regular and frequent injections. Oral therapies represent new treatment options for this chronic disease.
Read More
1st September, 2010
Your participation in clinical trials can help find a cure for MS.
Read More